Skip to main content

Panier

Vous profitez des avantages réservés aux VIP !

Article(s) non disponible(s) à la vente
Veuillez vérifier votre panier. Vous pouvez supprimer le ou les articles qui ne sont pas disponibles maintenant ou nous les supprimerons automatiquement au moment du règlement de la commande.
articlesarticle
articlesarticle

Recommandé pour vous

Loading...
  • Approaching China's Pharmaceutical Market

    A Fundamental Guide to Clinical Drug Development

    Modifié par Ming Q. Lu ...
    Collections series Biomedical and Life Sciences (R0)
    This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western ... En savoir plus

    $179.99 CAD

Les lecteurs de ce roman ont aussi aimé

  • The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    par John Geigert ...
    This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval. Since the first edition published ... En savoir plus

    $217.99 CAD

  • Sterile Product Development

    Formulation, Process, Quality and Regulatory Considerations

    Collections series Biomedical and Life Sciences (R0)
    This comprehensive book encompasses various facets of sterile product development. Key concepts relevant to the successful development of sterile products are illustrated through case studies and are covered under three sections in this book:• Formulation approaches that discuss a variety of dosage forms including protein therapeutics, lipid-based controlled delivery systems, PEGylated ... En savoir plus

    $421.99 CAD

  • Regulated Bioanalysis: Fundamentals and Practice

    Modifié par Mario L. Rocci Jr., Stephen Lowes ...
    Collections series Biomedical and Life Sciences (R0)
    The editors have engaged leading scientists in the field to participate in the development of this book, which is envisioned as a “one of a kind” contribution to the field. The book is a comprehensive text that puts fundamental bioanalytical science in context with current practice, its challenges and ongoing developments. It expands on existing texts on the subject by covering regulated ... En savoir plus

    $166.99 CAD

  • The Anticipation of Converging Industries

    A Concept Applied to Nutraceuticals and Functional Foods

    Collections series Engineering (R0)
    The blurring of boundaries between hitherto distinct scientific disciplines, technologies or markets is a common and powerful phenomenon. Subjects of this convergence often change consumer behaviours, favouring products and platforms with multiple functions. The Anticipation of Converging Industries provides a detailed focus on the triggers, drivers and consequences of convergence to create a more ... En savoir plus

    $179.39 CAD

  • Progress in the Chemistry of Organic Natural Products 105

    Collections series Chemistry and Material Science (R0)
    The first contribution reviews the occurrence of xanthine alkaloids in the plant kingdom and the elucidation of the caffeine biosynthesis pathway, providing details of the N-methyltransferases, belonging to the motif B' methyltransferase family which catalyze three steps in the four step pathway leading from xanthosine to caffeine. The second contribution in this book provides a background on the ... En savoir plus

    $217.79 CAD

  • Family Business and Technological Innovation

    Empirical Insights from the Italian Pharmaceutical Industry

    Collections series Business and Management (R0)
    This book explores technological innovation in family firms, seeking to reconstruct the links between the heterogeneous dimensions of family businesses and their innovative behaviour. Building on and examining the traditional view of family firms as conservative, this book contributes to knowledge surrounding the puzzling role of family firms in technological innovation, with particular focus on ... En savoir plus

    $64.09 CAD

  • FDA Bioequivalence Standards

    Modifié par Lawrence X. Yu, Bing V. Li ...
    Collections series Biomedical and Life Sciences (R0)
    This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, ... En savoir plus

    $280.49 CAD

  • Pharmacokinetics in Drug Development

    Advances and Applications, Volume 3

    Modifié par Peter L. Bonate, Danny R. Howard ...
    Collections series Biomedical and Life Sciences (R0)
    The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams. They regard the practical considerations for assessment of selected special development populations. For example, they include characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor ... En savoir plus

    $256.99 CAD

  • Drug Delivery to the Brain

    Physiological Concepts, Methodologies and Approaches

    Collections series Biomedical and Life Sciences (R0)
    The development of new CNS drugs is notoriously difficult. Drugs must reach CNS target sites for action and these sites are protected by a number of barriers, the most important being the blood –brain barrier (BBB). Many factors are therefore critical to consider for CNS drug delivery, e.g. active/passive transport across the BBB, intra-brain distribution, and central/systemic pharmacokinetics, to ... En savoir plus

    $204.99 CAD

  • Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products

    Collections series Biomedical and Life Sciences (R0)
    The purpose of this publication is to introduce a new, simpler and more effective way in which to interpret pharmaceutical aerosol particle size data from orally inhaled products (OIPs). Currently, the compendial and regulatory requirements dictate the need for measurements by full resolution multi-stage cascade impactor (CI), a process that is demanding for the operator, time consuming, prone to ... En savoir plus

    $179.99 CAD

  • Commercial Plant-Produced Recombinant Protein Products

    Case Studies

    Modifié par John A. Howard, Elizabeth E. Hood ...
    Collections series Biomedical and Life Sciences (R0)
    Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the ... En savoir plus

    $115.29 CAD